A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial.

@article{Teirstein1998ASA,
  title={A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial.},
  author={Paul S. Teirstein and Vincent Massullo and Shirish Jani and Jeffrey J. Popma and Gary S. Mintz and Robert J. Russo and Richard A. Schatz and Erminia M. Guarneri and Stephen Steuterman and David A. Cloutier and Martin B. Leon and Prabhakar Tripuraneni},
  journal={International journal of radiation oncology, biology, physics},
  year={1998},
  volume={42 5},
  pages={1097-104}
}
INTRODUCTION In the Scripps Coronary Radiation to Inhibit Proliferation Poststenting (SCRIPPS) Trial, 192Ir significantly reduced angiographic, ultrasonographic, and clinical endpoints of restenosis. The objective of this analysis was to quantitate the impact of patient, lesion and technical characteristics on late angiographic outcome. METHODS Patients with restenotic, stented coronary lesions were randomized to receive either 192Ir or placebo sources. Late luminal loss and loss index were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…